Thermo Fisher Scientific Collaboration
First study to successfully demonstrate reprogramming of blood cell types using srRNA to produce functional iPSCs.
Request documentExplore the science behind Solupore® Integrated. Contact Avectas to discuss specific requirements or request full documents.
First study to successfully demonstrate reprogramming of blood cell types using srRNA to produce functional iPSCs.
Request documentA scalable, rapid & automated manufacturing platform, Solupore® Integrated, for autologous and allogeneic cell therapies.
Request documentSolupore® Integrated transfected cells isolated using Sony's CGX10 yield highly cytotoxic CAR-T cells.
Request documentIncreased functional potency of multi-edited CAR-T cells manufactured by a non-viral transfection system.
Request documentEnhanced Stem Cell Memory and Cytotoxic Function in Engineered T Cells Expanded for 7 days to >1.3×10⁹.
Request documentSolupore® Integrated Triple Knock-Out Transfected T-cell Expansion Equivalent to Untransfected in G-Rex Platform.
Request documentSolupore® Integrated Triple Knock-Out Transfected T-cell Expansion Equivalent to Untransfected in G-Rex® Platform.
Request documentNovel non-viral delivery method enabling efficient engineering of primary human T cells for ex vivo cell therapy applications.
Request documentVector-free intracellular delivery by reversible permeabilization.
Request documentAutomated, reproducible transfection system for delivery of RNA, DNA and protein to primary immune cells used in clinical cell therapy.
Request documentHow Solupore® Integrated accelerates the future of cell therapies through healthier and more functional cells.
Request documentSolupore® Integrated demonstrates superior cellular avidity, essential for optimising cell therapy processes.
Request documentSolupore® Integrated knock-in using GenScript GenExact™ single-stranded DNA.
Request documentActivation-Free Transfection with Solupore® Integrated: Preserving Naïve T-cell Phenotypes.
Request document